Long-term efficacy and safety of ixekizumab - interview with Andrew Blauvelt

MedicalDigest.org / CongressReport.eu ›

08:45 | Jun 2nd, 2022

Dr. Andrew Blauvelt is the first author of a recent paper which analyzes long-term efficacy and safety of ixekizumab in psoriasis. Dr. Blauvelt tell us what was the message of this study for the derma...Show More